Literature DB >> 17037535

Proteolysis of SARS-associated coronavirus spike glycoprotein.

Graham Simmons1, Andrew J Rennekamp, Paul Bates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17037535      PMCID： PMC7123722          DOI： 10.1007/978-0-387-33012-9_39

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  13 in total

1.  Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.

Authors:  Graham Simmons; Jacqueline D Reeves; Andrew J Rennekamp; Sean M Amberg; Andrew J Piefer; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

2.  DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.

Authors:  Andrea Marzi; Thomas Gramberg; Graham Simmons; Peggy Möller; Andrew J Rennekamp; Mandy Krumbiegel; Martina Geier; Jutta Eisemann; Nadine Turza; Bertrand Saunier; Alexander Steinkasserer; Stephan Becker; Paul Bates; Heike Hofmann; Stefan Pöhlmann
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

4.  Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.

Authors:  Graham Simmons; Dhaval N Gosalia; Andrew J Rennekamp; Jacqueline D Reeves; Scott L Diamond; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

5.  CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.

Authors:  Scott A Jeffers; Sonia M Tusell; Laura Gillim-Ross; Erin M Hemmila; Jenna E Achenbach; Gregory J Babcock; William D Thomas; Larissa B Thackray; Mark D Young; Robert J Mason; Donna M Ambrosino; David E Wentworth; James C Demartini; Kathryn V Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-20       Impact factor: 11.205

6.  pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN.

Authors:  Zhi-Yong Yang; Yue Huang; Lakshmanan Ganesh; Kwanyee Leung; Wing-Pui Kong; Owen Schwartz; Kanta Subbarao; Gary J Nabel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.

Authors:  Berend Jan Bosch; Byron E E Martina; Ruurd Van Der Zee; Jean Lepault; Bert Jan Haijema; Cees Versluis; Albert J R Heck; Raoul De Groot; Albert D M E Osterhaus; Peter J M Rottier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-18       Impact factor: 11.205

8.  LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus.

Authors:  Thomas Gramberg; Heike Hofmann; Peggy Möller; Patricia F Lalor; Andrea Marzi; Martina Geier; Mandy Krumbiegel; Thomas Winkler; Frank Kirchhoff; David H Adams; Stephan Becker; Jan Münch; Stefan Pöhlmann
Journal:  Virology       Date:  2005-09-30       Impact factor: 3.616

9.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

Authors:  Wenhui Li; Michael J Moore; Natalya Vasilieva; Jianhua Sui; Swee Kee Wong; Michael A Berne; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Thomas C Greenough; Hyeryun Choe; Michael Farzan
Journal:  Nature       Date:  2003-11-27       Impact factor: 49.962

10.  Structural characterization of the SARS-coronavirus spike S fusion protein core.

Authors:  Brian Tripet; Megan W Howard; Michael Jobling; Randall K Holmes; Kathryn V Holmes; Robert S Hodges
Journal:  J Biol Chem       Date:  2004-03-02       Impact factor: 5.157
View more
  7 in total

1.  A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.

Authors:  Yanchen Zhou; Kai Lu; Susanne Pfefferle; Stephanie Bertram; Ilona Glowacka; Christian Drosten; Stefan Pöhlmann; Graham Simmons
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

2.  Increased LAMP1 Expression Enhances SARS-CoV-1 and SARS-CoV-2 Production in Vero-Derived Transgenic Cell Lines.

Authors:  A A Dolskiy; I V Grishchenko; S A Bodnev; A A Nazarenko; A M Smirnova; A K Matveeva; L E Bulychev; A S Ovchinnikova; T V Tregubchak; A V Zaykovskaya; I R Imatdinov; O V Pyankov; E V Gavrilova; R A Maksyutov; D V Yudkin
Journal:  Mol Biol       Date:  2022-06-03       Impact factor: 1.540

3.  Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy.

Authors:  Matteo Porotto; Gianmarco Orefice; Christine C Yokoyama; Bruce A Mungall; Ronald Realubit; Michael L Sganga; Mohamad Aljofan; Michael Whitt; Fraser Glickman; Anne Moscona
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

4.  Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.

Authors:  Sandrine Belouzard; Victor C Chu; Gary R Whittaker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

5.  Single particle assay of coronavirus membrane fusion with proteinaceous receptor-embedded supported bilayers.

Authors:  Deirdre A Costello; Jean K Millet; Chih-Yun Hsia; Gary R Whittaker; Susan Daniel
Journal:  Biomaterials       Date:  2013-07-22       Impact factor: 12.479

6.  A second functional furin site in the SARS-CoV-2 spike protein.

Authors:  Yue Zhang; Li Zhang; Jiajing Wu; Yuanling Yu; Shuo Liu; Tao Li; Qianqian Li; Ruxia Ding; Haixin Wang; Jianhui Nie; Zhimin Cui; Yulin Wang; Weijin Huang; Youchun Wang
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

Review 7.  The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Authors:  Lanying Du; Yuxian He; Yusen Zhou; Shuwen Liu; Bo-Jian Zheng; Shibo Jiang
Journal:  Nat Rev Microbiol       Date:  2009-02-09       Impact factor: 60.633
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.